Absci

Absci was founded in 2011 with the goal of making biological drug discovery and development more efficient through engineered biology. In 2026 Absci positions itself at the intersection of artificial intelligence and experimental biology, using models alongside laboratory validation rather than treating drug design as a purely computational task.